Review

Advances of prevention and management for post-pancreatectomy acute pancreatitis

  • CHEN Haoda ,
  • SHEN Baiyong
Expand
  • Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Key Laboratory of Pancreatic Neoplasms Translational Research, Research Institute of Pancreatic Diseases, Shanghai Jiao Tong University School of Medicine; State Key Laboratory of Systems Medicine for Cancer; Institute of Translational MedicineShanghai Jiao Tong University, Shanghai 200025, China

Received date: 2025-07-11

  Online published: 2026-01-26

Abstract

Post-pancreatectomy acute pancreatitis (PPAP) is a common complication following pancreatic surgery, characterized primarily by early postoperative local and systemic inflammatory responses. These responses can trigger a series of subsequent complications, significantly impacting patient’s clinical outcomes. In recent years, PPAP has been recognized as a distinct postoperative complication, and the International Study Group of Pancreatic Surgery (ISGPS) has proposed standardized definitions and grading criteria for it, which required a combination of postoperative enzyme elevation, imaging features, and changes in clinical management. This has garnered widespread attention within the field of pancreatic surgery. The occurrence of PPAP is closely related to microcirculatory disturbances. Clinically, it can manifest as self-limiting inflammation and is closely associated with pancreatic fistula development. In some cases, it may progress to necrotizing pancreatitis, potentially requiring surgical intervention. Current prevention and management strategies focus on intraoperative preservation of pancreatic blood supply, perioperative use of anti-inflammatory medications, and symptomatic supportive care. However, the diagnostic criteria, pathogenesis, and comprehensive management framework for PPAP still require further research and refinement.

Cite this article

CHEN Haoda , SHEN Baiyong . Advances of prevention and management for post-pancreatectomy acute pancreatitis[J]. Journal of Surgery Concepts & Practice, 2025 , 30(06) : 524 -528 . DOI: 10.16139/j.1007-9610.2025.06.11

References

[1] KAMARAJAH S K, BUNDRED J R, MARC O S, et al. A systematic review and network meta-analysis of different surgical approaches for pancreaticoduodenectomy[J]. HPB (Oxford), 2020, 22(3):329-339.
[2] LOOS M, KESTER T, KLAIBER U, et al. Arterial resection in pancreatic cancer surgery[J]. Ann Surg, 2022, 275(4):759-768.
[3] AUSANIA F, MARTINEZ-PéREZ A, SENRA DEL RIO P, et al. Multifactorial mitigation strategy to reduce clinically relevant pancreatic fistula in high-risk pancreatojejunostomy following pancreaticoduodenectomy[J]. Pancreatology, 2021, 21(2):466-472.
[4] GROUP P S, WRITING G, HALLE-SMITH J M, et al. Perioperative interventions to reduce pancreatic fistula following pancreatoduodenectomy: meta-analysis[J]. Br J Surg, 2022, 109(9):812-821.
[5] CONNOR S. Defining post-operative pancreatitis as a new pancreatic specific complication following pancreatic resection[J]. HPB (Oxford), 2016, 18(8):642-651.
[6] BANNONE E, ANDRIANELLO S, MARCHEGIANI G, et al. Postoperative acute pancreatitis following pancreaticoduodenectomy: a determinant of fistula potentially driven by the intraoperative fluid management[J]. Ann Surg, 2018, 268(5):815-822.
[7] CHEN H, WANG W, YING X, et al. Predictive factors for postoperative pancreatitis after pancreaticoduodenectomy: a single-center retrospective analysis of 1 465 patients[J]. Pancreatology, 2020, 20(2):211-216.
[8] MAGGINO L, MARCHEGIANI G, ZYROMSKI N J, et al. SSAT GI surgery debate: hepatobiliary and pancreas: is post-pancreatectomy acute pancreatitis a relevant clinical entity?[J]. J Gastrointest Surg, 2022, 26(1):60-63.
[9] MARCHEGIANI G, BARRETO S G, BANNONE E, et al. Postpancreatectomy acute pancreatitis (PPAP)[J]. Ann Surg, 2022, 275(4):663-672.
[10] PERRYMAN R G, HOERR S O. Observations on postoperative pancreatitis and postoperative elevation of the serum amylase[J]. Am J Surg, 1954, 88(3):417-420.
[11] PONKA J L, LANDRUM S E, CHAIKOF L. Acute pancreatitis in the postoperative patient[J]. Arch Surg, 1961, 83:475-490.
[12] R?TY S, SAND J, NORDBACK I. Detection of post-operative pancreatitis after pancreatic surgery by urine trypsinogen strip test[J]. Br J Surg, 2007, 94(1):64-69.
[13] KüHLBREY C M, SAMIEI N, SICK O, et al. Pancreatitis after pancreatoduodenectomy predicts clinically relevant postoperative pancreatic fistula[J]. J Gastrointest Surg, 2017, 21(2):330-338.
[14] LOOS M, STROBEL O, DIETRICH M, et al. Hyperamylasemia and acute pancreatitis after pancreatoduodenectomy: two different entities[J]. Surgery, 2021, 169(2):369-376.
[15] ZYROMSKI N J. Postpancreatectomy acute pancreatitis: fact? fiction? functional definition and future[J]. Surgery, 2021, 169(4):738-739.
[16] SATO A, TANI A, MISHIMA Y, et al. Assessment of two different criteria for post-pancreatectomy acute pancreatitis: a single-center retrospective analysis and literature review[J]. HPB(Oxford), 2025, 27(8):1060-1069.
[17] THYEN A J, MAATMAN T K, ROCH A M, et al. Post-pancreatectomy acute pancreatitis (PPAP) - a global definition with variable regional recognition[J]. HPB(Oxford), 2025, 27(9):1236-1238.
[18] BANNONE E, CATTELANI A, CORVINO G, et al. Clinical and financial validation of the international study group for pancreatic surgery (ISGPS) definition of post-pancreatectomy acute pancreatitis (PPAP)[J]. Ann Surg,2024:39435540.
[19] CHEN H, WANG C, SHEN Z, et al. Postpancreatectomy acute pancreatitis after pancreaticoduodenectomy[J]. Ann Surg, 2023, 278(2):e278-e283.
[20] JI Y, CHEN H, XU Z, et al. The proinflammatory status, based on preoperative interleukin‐6, predicts postpancreatectomy acute pancreatitis and associated postoperative pancreatic fistula after pancreaticoduodenectomy[J]. J Gastroen Hepatol, 2024, 40(1):315-324.
[21] CHEN H, WANG C, XIA W, et al. Early prediction of post-pancreatectomy acute pancreatitis after pancreaticoduodenectomy based on serum C-reactive protein[J]. Pancreatology, 2025, 25(2):208-213.
[22] PERRI G, MARCHEGIANI G, PARTELLI S, et al. Either high or low risk[J]. Ann Surg, 2023, 278(6):e1242-e1249.
[23] GAJDA M, GRUDZI?SKA E, SZMIGIEL P, et al. Risk factors of postoperative acute pancreatitis and its impact on the postoperative course after pancreaticoduodenectomy—10 years of single-center experience[J]. Life(Basel), 2023, 13(12):2344.
[24] CUTHBERTSON C M, CHRISTOPHI C. Disturbances of the microcirculation in acute pancreatitis[J]. Br J Surg, 2006, 93(5):518-530.
[25] DOUSSOT A, DECROCK M, CALAME P, et al. Fluorescence-based pancreas stump perfusion is associated with postoperative acute pancreatitis after pancreatoduodenectomy a prospective cohort study[J]. Pancreatology, 2021, 21(6):1023-1029.
[26] MAHARJAN D K, MAHARJAN P, LIMBU Y, et al. Role of indocyanine green to look for vascularity of the pancreatic stump during whipple's procedure and its clinical implications in terms of post-pancreatectomy acute pancreatitis and postoperative pancreatic fistula[J]. BMJ SIT, 2025, 7(1):e000318.
[27] CHEN H, FU N, ZHONG J, et al. Enhancement pattern of the pancreatic parenchyma predicts postpancreatectomy acute pancreatitis after pancreaticoduodenectomy[J]. Eur Radiol, 2023, 34(1):6-15.
[28] CHEN H, YANG Y, FU N, et al. Multiparameter pancreatic parenchyma assessment using dual-layer spectral-detector CT for postpancreatectomy acute pancreatitis prediction[J]. Abdom Radiol,2025:40619481.
[29] BAI X H, YIN J, YU S Y, et al. Extracellular volume fraction derived from dual-energy CT: a potential predictor for acute pancreatitis after pancreatoduodenectomy[J]. Eur Radiol, 2024, 34(11):6957-6966.
[30] CHEN H, WANG W, FU N, et al. Characterization of pancreatic fistula after post-pancreatectomy acute pancreatitis[J]. Ann Surg, 2024, 282(6):1045-1051.
[31] ROUSEK M, KACHLíK D, ZáRUBA P, et al. Vascular supply of postresection pancreatic remnant after pancreaticoduodenectomy: a cadaveric study[J]. Medicine(Baltimore), 2023, 102(36):e35049.
[32] DREAMS Trial Collaborators and West Midlands Research Collaborative. Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial)[J]. BMJ, 2017,357:j1455.
[33] ASEHNOUNE K, LE MOAL C, LEBUFFE G, et al. Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery: multicentre, double blind, randomised controlled trial[J]. BMJ, 2021,373:n1162.
[34] ZHANG T, XU Y, YAO Y, et al. Randomized controlled trial: perioperative dexamethasone reduces excessive postoperative inflammatory response and ileus after surgery for inflammatory bowel disease[J]. Inflamm Bowel Dis, 2021, 27(11):1756-1765.
[35] CORCORAN T B, MYLES P S, FORBES A B, et al. Dexamethasone and surgical-site infection[J]. N Engl J Med, 2021, 384(18):1731-1741.
[36] LAANINEN M, SAND J, NORDBACK I, et al. Perioperative hydrocortisone reduces major complications after pancreaticoduodenectomy: a randomized controlled trial[J]. Ann Surg, 2016, 264(5):696-702.
[37] CHEN H, WANG Y, WANG C, et al. The effect of perioperative of dexamethasone on postoperative complications after pancreaticoduodenectomy (PANDEX): a study protocol for a pragmatic multicenter randomized controlled trial[J]. Trials, 2023, 24(1):569.
[38] MAATMAN T K, ZYROMSKI N J. Surgical step-up approach in management of necrotizing pancreatitis[J]. Gastroenterol Clin N, 2025, 54(1):53-74.
[39] SHINOHARA M, HASHIMOTO M, NAGAO R, et al. A case of acute pancreatitis after pancreatectomy in grade C leading to walled-off necrosis successfully treated with necrosectomy by retroperitoneal approach[J]. Surg Case Rep, 2025, 11(1):24-0002.
[40] GROEN J V, SMITS F J, KOOLE D, et al. Completion pancreatectomy or a pancreas-preserving procedure during relaparotomy for pancreatic fistula after pancreatoduodenectomy: a multicentre cohort study and meta-analysis[J]. Br J Surg, 2021, 108(11):1371-1379.
Outlines

/